BREAKING NEWS

US FDA approves Pfizer's COVID antiviral pill

The US Food and Drug Administration on Thursday granted a full approval to Pfizer's PFE.N Paxlovid, an oral antiviral COVID-19 treatment for adults at high risk of progression to severe disease.

The pill was initially authorized for emergency use in the US in late 2021.

Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy